1. Home
  2. USAS vs KARD Comparison

USAS vs KARD Comparison

Compare USAS & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$4.31

Market Cap

1.5B

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$19.96

Market Cap

1.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
USAS
KARD
Founded
1998
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
USAS
KARD
Price
$4.31
$19.96
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.50
N/A
AVG Volume (30 Days)
3.7M
264.3K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$174.68
N/A
Revenue Next Year
$53.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$19.58
52 Week High
$10.50
$27.00

Technical Indicators

Market Signals
Indicator
USAS
KARD
Relative Strength Index (RSI) N/A 41.09
Support Level N/A $19.71
Resistance Level N/A $24.82
Average True Range (ATR) 0.00 1.60
MACD 0.00 -0.19
Stochastic Oscillator 0.00 7.15

Price Performance

Historical Comparison
USAS
KARD

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: